Dr. Mark Gerald Levano is a Bethpage, New York based male chiropractor who is specialized as General Chiropractor. Active license number of Dr. Mark Gerald Levano as General Chiropractor is 004033-2 in New York. Dr. Mark Gerald Levano is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Mark Gerald Levano speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
D.C.
Gender:
Male
Practice Address:
112 Haypath Rd, Bethpage, New York, 11714-1427
Phone:
516-433-7168
Fax:
516-938-5773
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1730136664
NPI Enumeration Date:
27 May, 2006
NPI Last Update On:
18 Jun, 2013
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Mark Gerald Levano are as mentioned below.
License Number
Specialization
State
Status
004033-2
Chiropractor
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
112 Haypath Rd, Bethpage, New York
Zip:
11714-1427
Phone Number:
516-433-7168
Fax Number:
516-938-5773
Patients can reach Dr. Mark Gerald Levano at 112 Haypath Rd, Bethpage, New York or can call to book an appointment on 516-433-7168. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.